Particle Size Analysis Market by Product (Laser Diffraction, DLS, Imaging, Coulter Principle, Sieving, Nanoparticle Tracking), Dispersion (Wet, Dry, Spray), Enduser (Pharma-Biopharma, Cosmeceutical, Chemical, Mining, F&B, Academia) Global Forecast to 2031
The global particle size analysis market is projected to reach USD 7.73 billion by 2031 from USD 5.12 billion in 2025, at a CAGR of 6.5% from 2026 to 2031. Growing demand for pharmaceuticals, biologics, and nanotechnology is increasing the need for precise particle-size characterization to maintain product quality and performance. At the same time, the market is moving toward advanced, automated, and AI-driven analytical systems that enable faster, high-throughput, and more accurate measurements.
“The laser diffraction segment held the largest share of the market in 2025.”
Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, Coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. In 2025, the laser diffraction segment holds the largest share in the particle size analysis market. The laser diffraction segment is experiencing strong growth in the particle size analysis market due to its high accuracy, speed, and versatility across a wide particle size range, making it suitable for both wet and dry sample analysis across industries such as pharmaceuticals, chemicals, food, and mining. A key trend driving its adoption is the increasing demand for precise quality control and regulatory compliance, especially in biopharma and advanced materials, where consistent particle size is critical for product performance.
“The wet dispersion segment held the largest share of the market in 2025.”
Based on dispersion, the particle size analysis market is segmented into wet, dry, and spray dispersion. In 2025, the wet dispersion segment holds the largest share in the particle size analysis market. The wet dispersion segment is growing strongly in the particle size analysis market due to its ability to deliver highly accurate, reproducible, and reliable measurements for fine particles, suspensions, and emulsions, which are increasingly used in pharmaceuticals, nanotechnology, and advanced materials. A key trend driving this growth is the rising demand for liquid-based formulations such as biologics, drug suspensions, and chemical slurries, in which wet dispersion provides better particle separation and minimizes agglomeration, thereby improving data precision.
“The healthcare industry segment held the largest share of the market in 2025.”
Based on end user, the particle size analysis market is segmented into the healthcare industry (pharmaceutical and biotechnology companies, public and private research institutions, academic institutions), cosmetic industry, chemical and petroleum industry, mining, minerals, and cement industry, food and beverages industry, and other industries. In 2025, the healthcare industry segment holds the largest share in the particle size analysis market. The healthcare end-user segment is witnessing strong growth in the particle size analysis market due to the increasing demand for advanced drug development, biologics, and nanoparticle-based therapies, where precise particle characterization is critical for safety and efficacy. The rising focus on drug delivery systems, vaccines, diagnostic assays, and medical devices is further driving adoption, as particle size directly impacts bioavailability, stability, and performance. Additionally, growing investments in pharmaceutical R&D, expanding healthcare infrastructure, and strict regulatory requirements are pushing the need for accurate and reliable particle analysis solutions, making healthcare one of the fastest-growing segments in the market.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Asia-Pacific is emerging as the fastest-growing region in the particle size analysis market, driven by rapid industrialization, expanding pharmaceutical and chemical manufacturing, and increasing investments in nanotechnology and R&D across countries like China, India, Japan, and South Korea. The region benefits from strong government support, growing regulatory focus on product quality, and rising adoption of advanced analytical technologies in industries such as healthcare, electronics, and materials science. Additionally, the presence of cost-effective manufacturing, a large skilled workforce, and increasing global company expansion into emerging markets is accelerating demand for particle size analysis instruments, making Asia Pacific the key growth engine for the market.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the particle size analysis market based on technology, dispersion, type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by growth trends and forecasts revenue for the market segments across five main regions (and the respective countries within these regions).
Reasons to Buy the Report
The report will help market leaders/new entrants with information on the closest approximations of revenue for the overall particle size analysis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain additional insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
“The laser diffraction segment held the largest share of the market in 2025.”
Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, Coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. In 2025, the laser diffraction segment holds the largest share in the particle size analysis market. The laser diffraction segment is experiencing strong growth in the particle size analysis market due to its high accuracy, speed, and versatility across a wide particle size range, making it suitable for both wet and dry sample analysis across industries such as pharmaceuticals, chemicals, food, and mining. A key trend driving its adoption is the increasing demand for precise quality control and regulatory compliance, especially in biopharma and advanced materials, where consistent particle size is critical for product performance.
“The wet dispersion segment held the largest share of the market in 2025.”
Based on dispersion, the particle size analysis market is segmented into wet, dry, and spray dispersion. In 2025, the wet dispersion segment holds the largest share in the particle size analysis market. The wet dispersion segment is growing strongly in the particle size analysis market due to its ability to deliver highly accurate, reproducible, and reliable measurements for fine particles, suspensions, and emulsions, which are increasingly used in pharmaceuticals, nanotechnology, and advanced materials. A key trend driving this growth is the rising demand for liquid-based formulations such as biologics, drug suspensions, and chemical slurries, in which wet dispersion provides better particle separation and minimizes agglomeration, thereby improving data precision.
“The healthcare industry segment held the largest share of the market in 2025.”
Based on end user, the particle size analysis market is segmented into the healthcare industry (pharmaceutical and biotechnology companies, public and private research institutions, academic institutions), cosmetic industry, chemical and petroleum industry, mining, minerals, and cement industry, food and beverages industry, and other industries. In 2025, the healthcare industry segment holds the largest share in the particle size analysis market. The healthcare end-user segment is witnessing strong growth in the particle size analysis market due to the increasing demand for advanced drug development, biologics, and nanoparticle-based therapies, where precise particle characterization is critical for safety and efficacy. The rising focus on drug delivery systems, vaccines, diagnostic assays, and medical devices is further driving adoption, as particle size directly impacts bioavailability, stability, and performance. Additionally, growing investments in pharmaceutical R&D, expanding healthcare infrastructure, and strict regulatory requirements are pushing the need for accurate and reliable particle analysis solutions, making healthcare one of the fastest-growing segments in the market.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Asia-Pacific is emerging as the fastest-growing region in the particle size analysis market, driven by rapid industrialization, expanding pharmaceutical and chemical manufacturing, and increasing investments in nanotechnology and R&D across countries like China, India, Japan, and South Korea. The region benefits from strong government support, growing regulatory focus on product quality, and rising adoption of advanced analytical technologies in industries such as healthcare, electronics, and materials science. Additionally, the presence of cost-effective manufacturing, a large skilled workforce, and increasing global company expansion into emerging markets is accelerating demand for particle size analysis instruments, making Asia Pacific the key growth engine for the market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Research Coverage
This report studies the particle size analysis market based on technology, dispersion, type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by growth trends and forecasts revenue for the market segments across five main regions (and the respective countries within these regions).
Reasons to Buy the Report
The report will help market leaders/new entrants with information on the closest approximations of revenue for the overall particle size analysis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain additional insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
- Analysis of key drivers (Growing demand for precision in pharmaceuticals & biologics), restraints (High cost of advanced instruments), opportunities (inline & real-time monitoring in manufacturing), and challenges (skill gap in advanced analytics) influencing the growth of the life science instrumentation market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the particle size analysis market
- Market Development: Comprehensive information about lucrative markets–the report analyzes the particle size analysis market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the particle size analysis market
- Competitive Assessment: In-depth assessment of market share, growth strategies, and service offerings of leading players like Spectris (UK), HORIBA (Japan), Danaher (US), Anton Paar GmbH (Austria), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), and others.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN PARTICLE SIZE ANALYSIS MARKET
2.4 HIGH GROWTH SEGMENTS
3 PREMIUM INSIGHTS
3.1 MARKET OVERVIEW
3.2 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY
3.3 REGIONAL SNAPSHOT OF PARTICLE SIZE ANALYSIS MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rapid Growth of mRNA, Lipid Nanoparticle (LNP), and Biologic Therapeutics Driving Demand for Precise Nanoparticle Characterization
4.2.1.2 AI-Enabled Automation and Intelligent Software Enhancing Operational Efficiency and Expanding Instrument Adoption
4.2.1.3 Increasing investments in pharmaceutical R&D
4.2.1.4 Stringent regulatory guidelines for product quality across industries
4.2.2 RESTRAINTS
4.2.2.1 High cost of particle size analyzers
4.2.2.2 Limitations in particle characterization range
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing number of conferences and events
4.2.3.2 Expanding applications of particle size analysis in quality control and contamination detection across emerging industries
4.2.4 CHALLENGES
4.2.4.1 Lack of well-established distribution network among SMEs
4.2.4.2 Limitations of laser diffraction technology
4.3 UNMET NEEDS AND WHITE SPACES
4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
5.1 KEY TECHNOLOGIES
5.1.1 LASER DIFFRACTION
5.1.2 COULTER PRINCIPLE (ELECTRICAL SENSING ZONE)
5.2 COMPLEMENTARY TECHNOLOGIES
5.2.1 DYNAMIC LIGHT SCATTERING (DLS)
5.2.2 NANOPARTICLE TRACKING ANALYSIS (NTA)
5.3 PATENT ANALYSIS
5.4 FUTURE APPLICATIONS
5.5 IMPACT OF AI/GEN AI ON PARTICLE SIZE ANALYSIS MARKET
5.5.1 TOP USE CASES AND MARKET POTENTIAL
5.5.2 BEST PRACTICES FOLLOWED BY COMPANIES IN PARTICLE SIZE ANALYSIS MARKET
5.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN PARTICLE SIZE ANALYSIS MARKET
5.5.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
5.5.5 CLIENT’S READINESS TO ADOPT AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET
5.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.6.1 KEY APPLICATIONS AND INDUSTRIAL OUTCOMES ENABLED BY PARTICLE SIZE ANALYZERS
6 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
6.1 DECISION-MAKING PROCESS
6.2 KEY STAKEHOLDERS IN BUYING PROCESS AND EVALUATION CRITERIA
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
6.2.2 KEY BUYING CRITERIA
6.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
6.4 UNMET NEEDS OF VARIOUS APPLICATIONS
7 REGULATORY ANALYSIS
7.1 NORTH AMERICA
7.1.1 US
7.1.1.1 Key regulatory bodies and government agencies
7.2 INDUSTRY STANDARDS
8 INDUSTRY TRENDS
8.1 PORTER’S FIVE FORCES ANALYSIS
8.1.1 THREAT FROM NEW ENTRANTS
8.1.2 THREAT FROM SUBSTITUTES
8.1.3 BARGAINING POWER OF SUPPLIERS
8.1.4 BARGAINING POWER OF BUYERS
8.1.5 INTENSITY OF COMPETITIVE RIVALRY
8.2 MACROECONOMIC OUTLOOK
8.2.1 INTRODUCTION
8.2.2 MACROECONOMIC INDICATORS
8.2.2.1 GDP trends and forecast
8.2.2.2 Trends in global particle size analysis market
8.3 VALUE CHAIN ANALYSIS
8.3.1 RAW MATERIAL SUPPLIERS
8.3.2 MANUFACTURERS
8.3.3 SALES & DISTRIBUTION
8.3.4 END USERS
8.4 ECOSYSTEM ANALYSIS
8.5 PRICING ANALYSIS
8.5.1 AVERAGE SELLING PRICE TREND, BY REGION
8.5.2 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER
8.6 TRADE DATA ANALYSIS
8.6.1 IMPORT DATA (HS CODE 903180)
8.6.2 EXPORT DATA (HS CODE 903180)
8.7 KEY CONFERENCES & EVENTS, 2026–2027
8.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
8.9 INVESTMENT & FUNDING SCENARIO
8.10 CASE STUDY ANALYSIS
8.10.1 CASE STUDY 1: ZETASIZER ULTRA VALIDATION FOR NANOPARTICLE CHARACTERIZATION
8.10.2 CASE STUDY 2: ZETPARTICLE CHARACTERIZATION FOR PHARMACEUTICAL APPLICATIONS
8.10.3 CASE STUDY 3: REAL-TIME VIABLE MONITORING IN PHARMACEUTICAL ASEPTIC MANUFACTURING
8.11 PARTICLE SIZE ANALYSIS MARKET - IMPACT OF US TARIFFS
8.11.1 INTRODUCTION
8.11.2 KEY TARIFF RATES
8.11.3 PRICE IMPACT ANALYSIS
8.11.4 IMPACT ON COUNTRY/REGION
8.11.4.1 US
8.11.4.2 Europe
8.11.4.3 Asia Pacific
8.11.5 IMPACT ON END USER
9 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
9.2 LASER DIFFRACTION
9.2.1 ADVANCED PARTICLE CHARACTERIZATION THROUGH AI-DRIVEN LASER DIFFRACTION TECHNOLOGIES TO DRIVE MARKET
9.3 DYNAMIC LIGHT SCATTERING
9.3.1 NEED FOR TRANSFORMING PARTICLE SIZE ANALYSIS THROUGH NEXT-GENERATION AI-DRIVEN DYNAMIC LIGHT SCATTERING (DLS) TECHNOLOGIES TO DRIVE MARKET
9.4 IMAGING
9.4.1 GROWTH OF IMAGING-BASED PARTICLE SIZE ANALYSIS THROUGH AUTOMATION AND AI INTEGRATION TO BOOST GROWTH
9.4.1.1 Dynamic imaging
9.4.1.2 Static imaging
9.5 NANOPARTICLE TRACKING ANALYSIS (NTA)
9.5.1 GROWTH OF NANOPARTICLE TRACKING ANALYSIS (NTA) IN ADVANCED SINGLE-PARTICLE CHARACTERIZATION AND BIOPHARMACEUTICAL APPLICATIONS TO BOOST GROWTH
9.6 COULTER PRINCIPLE
9.6.1 FOCUS ON STRENGTHENING GROWTH OF COULTER PRINCIPLE-BASED PARTICLE SIZE ANALYSIS THROUGH HIGH-PRECISION ELECTRICAL SENSING TO BOOST DEMAND
9.7 SIEVE ANALYSIS
9.7.1 DEVELOPMENT OF OTHER ADVANCED AND ACCURATE TECHNIQUES DISRUPTS GROWTH TO DRIVE MARKET
9.8 OTHER TECHNOLOGIES
10 PARTICLE SIZE ANALYSIS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HEALTHCARE INDUSTRY
10.2.1 ADVANCING PRECISION DIAGNOSTICS THROUGH HIGH-RESOLUTION PARTICLE CHARACTERIZATION
10.2.2 PHARMA COS
10.2.2.1 Increasing Regulatory Focus on Drug Quality and Growing Outsourcing of Particle Engineering Driving Adoption of Particle Size Analysis
10.2.2.2 Process analytical technology
10.2.2.2.1 Growing Adoption of Process Analytical Technology (PAT) and Continuous Manufacturing Accelerating Demand for Real-Time Particle Size Monitoring
10.2.2.3 Other applications
10.2.2.3.1 Expanding particle characterization across complex pharmaceutical manufacturing workflows
10.2.3 BIOPHARMA COS
10.2.3.1 Rapid Expansion of Biologics and Nanomedicines Driving Demand for Advanced Particle Characterization Technologies
10.2.3.2 Process analytical technology
10.2.3.2.1 Increasing adoption of process analytical technology in biopharmaceutical manufacturing driving real-time particle characterization
10.2.3.3 Other applications
10.2.3.3.1 Enhancing biologics development through advanced nanoparticle characterization
10.2.4 PUBLIC & PRIVATE RESEARCH INSTITUTIONS
10.2.4.1 Emphasis on strengthening drug development pipelines with AI-enabled particle size characterization technologies to drive market
10.2.5 ACADEMIC INSTITUTIONS
10.2.5.1 Need for strengthening university research capabilities with advanced particle size characterization technologies to drive market
10.3 COSMETIC INDUSTRY
10.3.1 RAPID USE OF PRECISION PARTICLE SIZE CONTROL AND NANO-FORMULATION TECHNOLOGIES TO BOOST MARKET
10.4 CHEMICAL & PETROLEUM INDUSTRY
10.4.1 NEED FOR MAINTAINING REFINERY AND PETROCHEMICAL EFFICIENCY VIA PRECISION PARTICLE SIZE ENGINEERING AND PROCESS OPTIMIZATION TO DRIVE MARKET
10.5 MINING, MINERALS, AND CEMENT INDUSTRY
10.5.1 NEED TO ACCELERATE SUSTAINABLE MINING AND CEMENT PRODUCTION THROUGH DIGITAL PARTICLE SIZE MONITORING AND SMART GRINDING SYSTEMS TO BOOST GROWTH
10.6 FOOD & BEVERAGE INDUSTRY
10.6.1 GROWING CONCERN OVER FOOD QUALITY & SAFETY COMPLIANCE, ESPECIALLY IN EMERGING COUNTRIES, TO DRIVE MARKET
10.7 OTHER INDUSTRIES
11 PARTICLE SIZE ANALYSIS MARKET, BY TYPE
11.1 INTRODUCTION
11.2 BENCHTOP ANALYZERS
11.2.1 WIDE-SCALE USE FOR ENHANCED PRECISION AND EFFICIENCY IN MODERN LABORATORIES TO DRIVE MARKET
11.3 PORTABLE ANALYZERS
11.3.1 REVOLUTIONIZING LANDSCAPE OF PARTICLE SIZE ANALYSIS TO BOOST GROWTH
12 PARTICLE SIZE ANALYSIS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Presence of large pharmaceutical and biotechnological companies to support market growth
12.2.2 CANADA
12.2.2.1 Increasing number of conferences on nanotechnology to drive growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Increasing number of conferences and workshops to push adoption of particle size analyzers
12.3.2 UK
12.3.2.1 Academia and research institutions to play major role in increased demand for particle size analyzers
12.3.3 FRANCE
12.3.3.1 Public-private investments in biotechnology and pharmaceutical R&D to support adoption of particle size analyzers
12.3.4 ITALY
12.3.4.1 Strong pharmaceutical manufacturing and R&D activities to support adoption of particle size analyzers
12.3.5 SPAIN
12.3.5.1 Favorable environment for pharma and biotech companies and SMEs to support demand
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Expanding pharmaceutical, nanotechnology, and research activities to drive demand for particle size analysis
12.4.2 JAPAN
12.4.2.1 Rising R&D expenditure to drive market
12.4.3 INDIA
12.4.3.1 Expanding pharmaceutical manufacturing and export capabilities to drive demand for particle size analysis
12.4.4 AUSTRALIA
12.4.4.1 Strong focus on pharmaceutical particle characterization and industrial particle analysis to support market growth
12.4.5 SOUTH KOREA
12.4.5.1 Strong government R&D investments and biotechnology innovation to drive market growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Expanding healthcare infrastructure and pharmaceutical activities to support demand for particle size analysis
12.5.2 MEXICO
12.5.2.1 Expanding mining, petroleum, and pharmaceutical industries to support demand for particle size analysis
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MULTIPLE CONFERENCES AND EXHIBITIONS TO PROMOTE UTILIZATION OF PARTICLE SIZE ANALYZERS
12.6.2 GCC COUNTRIES
12.6.2.1 Accelerating pharmaceutical quality infrastructure through advanced particle characterization
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PARTICLE SIZE ANALYSIS MARKET
13.3 REVENUE SHARE ANALYSIS
13.4 MARKET SHARE ANALYSIS
13.4.1 PARTICLE SIZE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
13.5 COMPANY VALUATION & FINANCIAL METRICS
13.5.1 FINANCIAL METRICS
13.5.2 COMPANY VALUATION
13.6 BRAND/PRODUCT COMPARISON
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.7.1 STARS
13.7.2 EMERGING LEADERS
13.7.3 PERVASIVE PLAYERS
13.7.4 PARTICIPANTS
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.8.1 PROGRESSIVE COMPANIES
13.8.2 RESPONSIVE COMPANIES
13.8.3 DYNAMIC COMPANIES
13.8.4 STARTING BLOCKS
13.8.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2025
13.8.5.1 Company footprint
13.8.5.2 Regional footprint
13.8.5.3 Technology footprint
13.8.5.4 Dispersion footprint
13.8.5.5 Type footprint
13.8.5.6 End user footprint
13.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.9.1 PROGRESSIVE COMPANIES
13.9.2 RESPONSIVE COMPANIES
13.9.3 DYNAMIC COMPANIES
13.9.4 STARTING BLOCKS
13.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES & APPROVALS
13.10.2 DEALS
13.10.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 SPECTRIS
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 HORIBA
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.4 Expansions
14.1.2.5 MnM view
14.1.2.5.1 Key strengths
14.1.2.5.2 Strategic choices
14.1.2.5.3 Weaknesses and competitive threats
14.1.3 DANAHER CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 MnM view
14.1.3.3.1 Key strengths
14.1.3.3.2 Strategic choices
14.1.3.3.3 Weaknesses and competitive threats
14.1.4 ANTON PAAR GMBH
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches & approvals
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Key Strengths
14.1.4.4.2 Strategic Choices
14.1.4.4.3 Weaknesses and Competitive Threats
14.1.5 BETTERSIZE INSTRUMENTS LTD.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches & approvals
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 NOVA VENTURES GROUP
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.7 FRITSCH GMBH
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches & approvals
14.1.8 LS INSTRUMENTS
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.8.3.2 Expansions
14.1.9 METTLER TOLEDO
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 VERDER SCIENTIFIC GMBH & CO. KG
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Deals
14.1.10.3.2 Expansions
14.1.11 SYMPATEC GMBH
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Expansions
14.1.12 SHIMADZU CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Expansions
14.1.13 TSI
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 DANDONG HMKTEST INSTRUMENT CO., LTD.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 MICROMERITICS INSTRUMENT CORPORATION
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Deals
14.2 OTHER PLAYERS
14.2.1 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH
14.2.2 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.
14.2.3 3P INSTRUMENTS
14.2.4 IZON SCIENCE LIMITED
14.2.5 CSC SCIENTIFIC COMPANY, INC.
14.2.6 INPROCESS-LSP
14.2.7 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC
14.2.8 APIX ANALYTICS
14.2.9 GENIZER LLC
14.2.10 TECHNOVALUE
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.1.2 Objectives of secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Objectives of primary research
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.1.1 Approach 1: Company revenue estimation approach
15.2.1.2 Approach 4: Primary interviews
15.2.2 TOP-DOWN APPROACH
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
15.4 MARKET SHARE ASSESSMENT
15.5 RESEARCH ASSUMPTIONS
15.6 RESEARCH LIMITATIONS
15.7 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN PARTICLE SIZE ANALYSIS MARKET
2.4 HIGH GROWTH SEGMENTS
3 PREMIUM INSIGHTS
3.1 MARKET OVERVIEW
3.2 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY
3.3 REGIONAL SNAPSHOT OF PARTICLE SIZE ANALYSIS MARKET
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rapid Growth of mRNA, Lipid Nanoparticle (LNP), and Biologic Therapeutics Driving Demand for Precise Nanoparticle Characterization
4.2.1.2 AI-Enabled Automation and Intelligent Software Enhancing Operational Efficiency and Expanding Instrument Adoption
4.2.1.3 Increasing investments in pharmaceutical R&D
4.2.1.4 Stringent regulatory guidelines for product quality across industries
4.2.2 RESTRAINTS
4.2.2.1 High cost of particle size analyzers
4.2.2.2 Limitations in particle characterization range
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing number of conferences and events
4.2.3.2 Expanding applications of particle size analysis in quality control and contamination detection across emerging industries
4.2.4 CHALLENGES
4.2.4.1 Lack of well-established distribution network among SMEs
4.2.4.2 Limitations of laser diffraction technology
4.3 UNMET NEEDS AND WHITE SPACES
4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
5.1 KEY TECHNOLOGIES
5.1.1 LASER DIFFRACTION
5.1.2 COULTER PRINCIPLE (ELECTRICAL SENSING ZONE)
5.2 COMPLEMENTARY TECHNOLOGIES
5.2.1 DYNAMIC LIGHT SCATTERING (DLS)
5.2.2 NANOPARTICLE TRACKING ANALYSIS (NTA)
5.3 PATENT ANALYSIS
5.4 FUTURE APPLICATIONS
5.5 IMPACT OF AI/GEN AI ON PARTICLE SIZE ANALYSIS MARKET
5.5.1 TOP USE CASES AND MARKET POTENTIAL
5.5.2 BEST PRACTICES FOLLOWED BY COMPANIES IN PARTICLE SIZE ANALYSIS MARKET
5.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN PARTICLE SIZE ANALYSIS MARKET
5.5.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
5.5.5 CLIENT’S READINESS TO ADOPT AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET
5.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.6.1 KEY APPLICATIONS AND INDUSTRIAL OUTCOMES ENABLED BY PARTICLE SIZE ANALYZERS
6 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
6.1 DECISION-MAKING PROCESS
6.2 KEY STAKEHOLDERS IN BUYING PROCESS AND EVALUATION CRITERIA
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
6.2.2 KEY BUYING CRITERIA
6.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
6.4 UNMET NEEDS OF VARIOUS APPLICATIONS
7 REGULATORY ANALYSIS
7.1 NORTH AMERICA
7.1.1 US
7.1.1.1 Key regulatory bodies and government agencies
7.2 INDUSTRY STANDARDS
8 INDUSTRY TRENDS
8.1 PORTER’S FIVE FORCES ANALYSIS
8.1.1 THREAT FROM NEW ENTRANTS
8.1.2 THREAT FROM SUBSTITUTES
8.1.3 BARGAINING POWER OF SUPPLIERS
8.1.4 BARGAINING POWER OF BUYERS
8.1.5 INTENSITY OF COMPETITIVE RIVALRY
8.2 MACROECONOMIC OUTLOOK
8.2.1 INTRODUCTION
8.2.2 MACROECONOMIC INDICATORS
8.2.2.1 GDP trends and forecast
8.2.2.2 Trends in global particle size analysis market
8.3 VALUE CHAIN ANALYSIS
8.3.1 RAW MATERIAL SUPPLIERS
8.3.2 MANUFACTURERS
8.3.3 SALES & DISTRIBUTION
8.3.4 END USERS
8.4 ECOSYSTEM ANALYSIS
8.5 PRICING ANALYSIS
8.5.1 AVERAGE SELLING PRICE TREND, BY REGION
8.5.2 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER
8.6 TRADE DATA ANALYSIS
8.6.1 IMPORT DATA (HS CODE 903180)
8.6.2 EXPORT DATA (HS CODE 903180)
8.7 KEY CONFERENCES & EVENTS, 2026–2027
8.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
8.9 INVESTMENT & FUNDING SCENARIO
8.10 CASE STUDY ANALYSIS
8.10.1 CASE STUDY 1: ZETASIZER ULTRA VALIDATION FOR NANOPARTICLE CHARACTERIZATION
8.10.2 CASE STUDY 2: ZETPARTICLE CHARACTERIZATION FOR PHARMACEUTICAL APPLICATIONS
8.10.3 CASE STUDY 3: REAL-TIME VIABLE MONITORING IN PHARMACEUTICAL ASEPTIC MANUFACTURING
8.11 PARTICLE SIZE ANALYSIS MARKET - IMPACT OF US TARIFFS
8.11.1 INTRODUCTION
8.11.2 KEY TARIFF RATES
8.11.3 PRICE IMPACT ANALYSIS
8.11.4 IMPACT ON COUNTRY/REGION
8.11.4.1 US
8.11.4.2 Europe
8.11.4.3 Asia Pacific
8.11.5 IMPACT ON END USER
9 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
9.2 LASER DIFFRACTION
9.2.1 ADVANCED PARTICLE CHARACTERIZATION THROUGH AI-DRIVEN LASER DIFFRACTION TECHNOLOGIES TO DRIVE MARKET
9.3 DYNAMIC LIGHT SCATTERING
9.3.1 NEED FOR TRANSFORMING PARTICLE SIZE ANALYSIS THROUGH NEXT-GENERATION AI-DRIVEN DYNAMIC LIGHT SCATTERING (DLS) TECHNOLOGIES TO DRIVE MARKET
9.4 IMAGING
9.4.1 GROWTH OF IMAGING-BASED PARTICLE SIZE ANALYSIS THROUGH AUTOMATION AND AI INTEGRATION TO BOOST GROWTH
9.4.1.1 Dynamic imaging
9.4.1.2 Static imaging
9.5 NANOPARTICLE TRACKING ANALYSIS (NTA)
9.5.1 GROWTH OF NANOPARTICLE TRACKING ANALYSIS (NTA) IN ADVANCED SINGLE-PARTICLE CHARACTERIZATION AND BIOPHARMACEUTICAL APPLICATIONS TO BOOST GROWTH
9.6 COULTER PRINCIPLE
9.6.1 FOCUS ON STRENGTHENING GROWTH OF COULTER PRINCIPLE-BASED PARTICLE SIZE ANALYSIS THROUGH HIGH-PRECISION ELECTRICAL SENSING TO BOOST DEMAND
9.7 SIEVE ANALYSIS
9.7.1 DEVELOPMENT OF OTHER ADVANCED AND ACCURATE TECHNIQUES DISRUPTS GROWTH TO DRIVE MARKET
9.8 OTHER TECHNOLOGIES
10 PARTICLE SIZE ANALYSIS MARKET, BY END USER
10.1 INTRODUCTION
10.2 HEALTHCARE INDUSTRY
10.2.1 ADVANCING PRECISION DIAGNOSTICS THROUGH HIGH-RESOLUTION PARTICLE CHARACTERIZATION
10.2.2 PHARMA COS
10.2.2.1 Increasing Regulatory Focus on Drug Quality and Growing Outsourcing of Particle Engineering Driving Adoption of Particle Size Analysis
10.2.2.2 Process analytical technology
10.2.2.2.1 Growing Adoption of Process Analytical Technology (PAT) and Continuous Manufacturing Accelerating Demand for Real-Time Particle Size Monitoring
10.2.2.3 Other applications
10.2.2.3.1 Expanding particle characterization across complex pharmaceutical manufacturing workflows
10.2.3 BIOPHARMA COS
10.2.3.1 Rapid Expansion of Biologics and Nanomedicines Driving Demand for Advanced Particle Characterization Technologies
10.2.3.2 Process analytical technology
10.2.3.2.1 Increasing adoption of process analytical technology in biopharmaceutical manufacturing driving real-time particle characterization
10.2.3.3 Other applications
10.2.3.3.1 Enhancing biologics development through advanced nanoparticle characterization
10.2.4 PUBLIC & PRIVATE RESEARCH INSTITUTIONS
10.2.4.1 Emphasis on strengthening drug development pipelines with AI-enabled particle size characterization technologies to drive market
10.2.5 ACADEMIC INSTITUTIONS
10.2.5.1 Need for strengthening university research capabilities with advanced particle size characterization technologies to drive market
10.3 COSMETIC INDUSTRY
10.3.1 RAPID USE OF PRECISION PARTICLE SIZE CONTROL AND NANO-FORMULATION TECHNOLOGIES TO BOOST MARKET
10.4 CHEMICAL & PETROLEUM INDUSTRY
10.4.1 NEED FOR MAINTAINING REFINERY AND PETROCHEMICAL EFFICIENCY VIA PRECISION PARTICLE SIZE ENGINEERING AND PROCESS OPTIMIZATION TO DRIVE MARKET
10.5 MINING, MINERALS, AND CEMENT INDUSTRY
10.5.1 NEED TO ACCELERATE SUSTAINABLE MINING AND CEMENT PRODUCTION THROUGH DIGITAL PARTICLE SIZE MONITORING AND SMART GRINDING SYSTEMS TO BOOST GROWTH
10.6 FOOD & BEVERAGE INDUSTRY
10.6.1 GROWING CONCERN OVER FOOD QUALITY & SAFETY COMPLIANCE, ESPECIALLY IN EMERGING COUNTRIES, TO DRIVE MARKET
10.7 OTHER INDUSTRIES
11 PARTICLE SIZE ANALYSIS MARKET, BY TYPE
11.1 INTRODUCTION
11.2 BENCHTOP ANALYZERS
11.2.1 WIDE-SCALE USE FOR ENHANCED PRECISION AND EFFICIENCY IN MODERN LABORATORIES TO DRIVE MARKET
11.3 PORTABLE ANALYZERS
11.3.1 REVOLUTIONIZING LANDSCAPE OF PARTICLE SIZE ANALYSIS TO BOOST GROWTH
12 PARTICLE SIZE ANALYSIS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Presence of large pharmaceutical and biotechnological companies to support market growth
12.2.2 CANADA
12.2.2.1 Increasing number of conferences on nanotechnology to drive growth
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Increasing number of conferences and workshops to push adoption of particle size analyzers
12.3.2 UK
12.3.2.1 Academia and research institutions to play major role in increased demand for particle size analyzers
12.3.3 FRANCE
12.3.3.1 Public-private investments in biotechnology and pharmaceutical R&D to support adoption of particle size analyzers
12.3.4 ITALY
12.3.4.1 Strong pharmaceutical manufacturing and R&D activities to support adoption of particle size analyzers
12.3.5 SPAIN
12.3.5.1 Favorable environment for pharma and biotech companies and SMEs to support demand
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Expanding pharmaceutical, nanotechnology, and research activities to drive demand for particle size analysis
12.4.2 JAPAN
12.4.2.1 Rising R&D expenditure to drive market
12.4.3 INDIA
12.4.3.1 Expanding pharmaceutical manufacturing and export capabilities to drive demand for particle size analysis
12.4.4 AUSTRALIA
12.4.4.1 Strong focus on pharmaceutical particle characterization and industrial particle analysis to support market growth
12.4.5 SOUTH KOREA
12.4.5.1 Strong government R&D investments and biotechnology innovation to drive market growth
12.4.6 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 BRAZIL
12.5.1.1 Expanding healthcare infrastructure and pharmaceutical activities to support demand for particle size analysis
12.5.2 MEXICO
12.5.2.1 Expanding mining, petroleum, and pharmaceutical industries to support demand for particle size analysis
12.5.3 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MULTIPLE CONFERENCES AND EXHIBITIONS TO PROMOTE UTILIZATION OF PARTICLE SIZE ANALYZERS
12.6.2 GCC COUNTRIES
12.6.2.1 Accelerating pharmaceutical quality infrastructure through advanced particle characterization
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PARTICLE SIZE ANALYSIS MARKET
13.3 REVENUE SHARE ANALYSIS
13.4 MARKET SHARE ANALYSIS
13.4.1 PARTICLE SIZE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
13.5 COMPANY VALUATION & FINANCIAL METRICS
13.5.1 FINANCIAL METRICS
13.5.2 COMPANY VALUATION
13.6 BRAND/PRODUCT COMPARISON
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.7.1 STARS
13.7.2 EMERGING LEADERS
13.7.3 PERVASIVE PLAYERS
13.7.4 PARTICIPANTS
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.8.1 PROGRESSIVE COMPANIES
13.8.2 RESPONSIVE COMPANIES
13.8.3 DYNAMIC COMPANIES
13.8.4 STARTING BLOCKS
13.8.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2025
13.8.5.1 Company footprint
13.8.5.2 Regional footprint
13.8.5.3 Technology footprint
13.8.5.4 Dispersion footprint
13.8.5.5 Type footprint
13.8.5.6 End user footprint
13.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES
13.9.1 PROGRESSIVE COMPANIES
13.9.2 RESPONSIVE COMPANIES
13.9.3 DYNAMIC COMPANIES
13.9.4 STARTING BLOCKS
13.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES & APPROVALS
13.10.2 DEALS
13.10.3 EXPANSIONS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 SPECTRIS
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 HORIBA
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.4 Expansions
14.1.2.5 MnM view
14.1.2.5.1 Key strengths
14.1.2.5.2 Strategic choices
14.1.2.5.3 Weaknesses and competitive threats
14.1.3 DANAHER CORPORATION
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 MnM view
14.1.3.3.1 Key strengths
14.1.3.3.2 Strategic choices
14.1.3.3.3 Weaknesses and competitive threats
14.1.4 ANTON PAAR GMBH
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches & approvals
14.1.4.3.2 Deals
14.1.4.3.3 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Key Strengths
14.1.4.4.2 Strategic Choices
14.1.4.4.3 Weaknesses and Competitive Threats
14.1.5 BETTERSIZE INSTRUMENTS LTD.
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches & approvals
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 NOVA VENTURES GROUP
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.7 FRITSCH GMBH
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches & approvals
14.1.8 LS INSTRUMENTS
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Deals
14.1.8.3.2 Expansions
14.1.9 METTLER TOLEDO
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.10 VERDER SCIENTIFIC GMBH & CO. KG
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Deals
14.1.10.3.2 Expansions
14.1.11 SYMPATEC GMBH
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.11.3 Recent developments
14.1.11.3.1 Expansions
14.1.12 SHIMADZU CORPORATION
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Expansions
14.1.13 TSI
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 DANDONG HMKTEST INSTRUMENT CO., LTD.
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 MICROMERITICS INSTRUMENT CORPORATION
14.1.15.1 Business overview
14.1.15.2 Products offered
14.1.15.3 Recent developments
14.1.15.3.1 Deals
14.2 OTHER PLAYERS
14.2.1 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH
14.2.2 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.
14.2.3 3P INSTRUMENTS
14.2.4 IZON SCIENCE LIMITED
14.2.5 CSC SCIENTIFIC COMPANY, INC.
14.2.6 INPROCESS-LSP
14.2.7 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC
14.2.8 APIX ANALYTICS
14.2.9 GENIZER LLC
14.2.10 TECHNOVALUE
15 RESEARCH METHODOLOGY
15.1 RESEARCH DATA
15.1.1 SECONDARY DATA
15.1.1.1 Key data from secondary sources
15.1.1.2 Objectives of secondary research
15.1.2 PRIMARY DATA
15.1.2.1 Objectives of primary research
15.1.2.2 Key industry insights
15.2 MARKET SIZE ESTIMATION
15.2.1 BOTTOM-UP APPROACH
15.2.1.1 Approach 1: Company revenue estimation approach
15.2.1.2 Approach 4: Primary interviews
15.2.2 TOP-DOWN APPROACH
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
15.4 MARKET SHARE ASSESSMENT
15.5 RESEARCH ASSUMPTIONS
15.6 RESEARCH LIMITATIONS
15.7 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 PARTICLE SIZE ANALYSIS MARKET: UNMET NEEDS
TABLE 2 STRATEGIC FOCUS OF TIER 1/2/3 PLAYERS
TABLE 3 KEY PATENTS, 2021–2026
TABLE 4 KEY COMPANIES IMPLEMENTING AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET
TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TECHNOLOGY
TABLE 6 KEY BUYING CRITERIA, BY TECHNOLOGY
TABLE 7 PARTICLE SIZE ANALYSIS MARKET: UNMET NEED ANALYSIS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 12 INDUSTRY STANDARDS FOR PARTICLE SIZE ANALYSIS MARKET
TABLE 13 PORTER’S FIVE FORCES ANALYSIS: PARTICLE SIZE ANALYSIS MARKET
TABLE 14 PARTICLE SIZE ANALYSIS MARKET: ROLE OF ECOSYSTEM
TABLE 15 AVERAGE SELLING PRICE OF LAB AUTOMATION EQUIPMENT, BY REGION, 2023–2025(USD THOUSAND)
TABLE 16 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER, 2025 (USD THOUSAND)
TABLE 17 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 18 EXPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 19 LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 21 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 22 LASER DIFFRACTION: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 23 DYNAMIC LIGHT SCATTERING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 24 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 25 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 26 DYNAMIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 27 STATIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 28 NANOPARTICLE TRACKING ANALYSIS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 29 COULTER PRINCIPLE: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 30 SIEVE ANALYSIS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 31 OTHER TECHNOLOGIES: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 32 PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 33 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 34 PHARMA AND BIOTECH COMPANIES: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 35 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 36 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 37 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 39 OTHER APPLICATIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 41 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 42 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 PUBLIC & PRIVATE RESEARCH INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 ACADEMIC INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 COSMETIC INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 47 CHEMICAL & PETROLEUM INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 MINING, MINERALS, AND CEMENT INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 FOOD & BEVERAGE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 50 OTHER END USERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 51 PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 52 BENCHTOP ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 PORTABLE ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 57 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 60 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 61 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUBINDUSTRY, 2024–2031 (USD MILLION)
TABLE 62 US: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 63 US: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 64 CANADA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 65 CANADA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 68 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 69 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 70 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 72 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 73 GERMANY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 74 GERMANY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 UK: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 76 UK: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 77 FRANCE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 78 FRANCE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 79 ITALY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 80 ITALY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81 SPAIN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 82 SPAIN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 84 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 88 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 91 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 92 CHINA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 93 CHINA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 JAPAN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 95 JAPAN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96 INDIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 97 INDIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 98 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 99 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 101 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 103 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 106 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2021–2028(USD MILLION)
TABLE 108 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 110 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 111 BRAZIL: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 112 BRAZIL: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 MEXICO: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 114 MEXICO: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 116 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 124 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 125 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 127 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 129 PARTICLE SIZE ANALYSIS MARKET: DEGREE OF COMPETITION
TABLE 130 PARTICLE SIZE ANALYSIS MARKET: REGION FOOTPRINT
TABLE 131 PARTICLE SIZE ANALYSIS MARKET: TECHNOLOGY FOOTPRINT
TABLE 132 PARTICLE SIZE ANALYSIS MARKET: DISPERSION FOOTPRINT
TABLE 133 PARTICLE SIZE ANALYSIS MARKET: TYPE FOOTPRINT
TABLE 134 PARTICLE-SIZE ANALYSIS MARKET: END USER FOOTPRINT
TABLE 135 PARTICLE SIZE ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 136 PARTICLE SIZE ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 137 PARTICLE SIZE ANALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022 TO MARCH 2026
TABLE 138 PARTICLE SIZE ANALYSIS MARKET: DEALS, JANUARY 2022 TO MARCH 2026
TABLE 139 PARTICLE SIZE ANALYSIS MARKET: EXPANSIONS, JANUARY 2022 TO MARCH 2026
TABLE 140 SPECTRIS: COMPANY OVERVIEW
TABLE 141 SPECTRIS: PRODUCTS OFFERED
TABLE 142 SPECTRIS: DEALS, JANUARY 2021–APRIL 2026
TABLE 143 HORIBA: COMPANY OVERVIEW
TABLE 144 HORIBA: PRODUCTS OFFERED
TABLE 145 HORIBA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 146 HORIBA: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 147 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 148 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 149 ANTON PAAR GMBH: COMPANY OVERVIEW
TABLE 150 ANTOR PAAR GMBH: PRODUCTS OFFERED
TABLE 151 ANTOR PAAR GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 152 ANTOR PAAR GMBH: DEALS, JANUARY 2021–APRIL 2026
TABLE 153 ANTOR PAAR GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 154 BETTERSIZE INSTRUMENTS LTD.: COMPANY OVERVIEW
TABLE 155 BETTERSIZE INSTRUMENTS LTD.: PRODUCTS OFFERED
TABLE 156 BETTERSIZE INSTRUMENTS LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 157 BETTERSIZE INSTRUMENTS LTD: DEALS, JANUARY 2021–APRIL 2026
TABLE 158 BETTERSIZE INSTRUMENTS LTD.: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 159 NOVA VENTURES GROUP: COMPANY OVERVIEW
TABLE 160 NOVA VENTURES GROUP: PRODUCTS OFFERED
TABLE 161 FRITSCH GMBH: COMPANY OVERVIEW
TABLE 162 FRITSCH GMBH: PRODUCTS OFFERED
TABLE 163 FRITSCH GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 164 LS INSTRUMENTS: COMPANY OVERVIEW
TABLE 165 LS INSTRUMENTS: PRODUCTS OFFERED
TABLE 166 LS INSTRUMENTS: DEALS, JANUARY 2021–APRIL 2026
TABLE 167 LS INSTRUMENTS: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 168 METTLER TOLEDO: COMPANY OVERVIEW
TABLE 169 METTLER TOLEDO: PRODUCTS OFFERED
TABLE 170 VERDER SCIENTIFIC GMBH & CO. KG: COMPANY OVERVIEW
TABLE 171 VERDER SCIENTIFIC GMBH & CO. KG: PRODUCTS OFFERED
TABLE 172 VERDER SCIENTIFIC GMBH & CO. KG: DEALS, JANUARY 2021–APRIL 2026
TABLE 173 VERDER SCIENTIFIC GMBH & CO. KG: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 174 SYMPATEC GMBH: COMPANY OVERVIEW
TABLE 175 SYMPATEC GMBH: PRODUCTS OFFERED
TABLE 176 SYMPATEC GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 177 SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 178 SHIMADZU CORPORATION: PRODUCTS OFFERED
TABLE 179 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 180 TSI: COMPANY OVERVIEW
TABLE 181 TSI: PRODUCTS OFFERED
TABLE 182 DANDONG HMKTEST INSTRUMENT CO., LTD.: COMPANY OVERVIEW
TABLE 183 DANDONG HMKTEST INSTRUMENT CO., LTD.: PRODUCTS OFFERED
TABLE 184 MICROMERITICS INSTRUMENT CORPORATION: COMPANY OVERVIEW
TABLE 185 MICROMERITICS INSTRUMENT CORPORATION: PRODUCTS OFFERED
TABLE 186 MICROMERITICS INSTRUMENT CORPORATION: DEALS, JANUARY 2021–APRIL 2026
TABLE 187 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH: COMPANY OVERVIEW
TABLE 188 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.: COMPANY OVERVIEW
TABLE 189 3P INSTRUMENTS: COMPANY OVERVIEW
TABLE 190 IZON SCIENCE LIMITED: COMPANY OVERVIEW
TABLE 191 CSC SCIENTIFIC COMPANY, INC.: COMPANY OVERVIEW
TABLE 192 INPROCESS-LSP: COMPANY OVERVIEW
TABLE 193 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC: COMPANY OVERVIEW
TABLE 194 APIX ANALYTICS: COMPANY OVERVIEW
TABLE 195 GENIZER LLC: COMPANY OVERVIEW
TABLE 196 TECHNOVALUE: COMPANY OVERVIEW
TABLE 197 PARTICLE SIZE ANALYSIS MARKET: RESEARCH ASSUMPTIONS
TABLE 198 RISK ASSESSMENT ANALYSIS
TABLE 1 PARTICLE SIZE ANALYSIS MARKET: UNMET NEEDS
TABLE 2 STRATEGIC FOCUS OF TIER 1/2/3 PLAYERS
TABLE 3 KEY PATENTS, 2021–2026
TABLE 4 KEY COMPANIES IMPLEMENTING AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET
TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TECHNOLOGY
TABLE 6 KEY BUYING CRITERIA, BY TECHNOLOGY
TABLE 7 PARTICLE SIZE ANALYSIS MARKET: UNMET NEED ANALYSIS
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
TABLE 12 INDUSTRY STANDARDS FOR PARTICLE SIZE ANALYSIS MARKET
TABLE 13 PORTER’S FIVE FORCES ANALYSIS: PARTICLE SIZE ANALYSIS MARKET
TABLE 14 PARTICLE SIZE ANALYSIS MARKET: ROLE OF ECOSYSTEM
TABLE 15 AVERAGE SELLING PRICE OF LAB AUTOMATION EQUIPMENT, BY REGION, 2023–2025(USD THOUSAND)
TABLE 16 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER, 2025 (USD THOUSAND)
TABLE 17 IMPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 18 EXPORT DATA FOR HS CODE 903180-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 19 LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 21 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 22 LASER DIFFRACTION: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 23 DYNAMIC LIGHT SCATTERING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 24 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 25 IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 26 DYNAMIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 27 STATIC IMAGING: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 28 NANOPARTICLE TRACKING ANALYSIS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 29 COULTER PRINCIPLE: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 30 SIEVE ANALYSIS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 31 OTHER TECHNOLOGIES: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 32 PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 33 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 34 PHARMA AND BIOTECH COMPANIES: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 35 HEALTHCARE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 36 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 37 PHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 39 OTHER APPLICATIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 41 BIOPHARMA COS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 42 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 43 PROCESS ANALYTICAL TECHNOLOGY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 44 PUBLIC & PRIVATE RESEARCH INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 ACADEMIC INSTITUTIONS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 46 COSMETIC INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 47 CHEMICAL & PETROLEUM INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48 MINING, MINERALS, AND CEMENT INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49 FOOD & BEVERAGE INDUSTRY: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 50 OTHER END USERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 51 PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 52 BENCHTOP ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 53 PORTABLE ANALYZERS: PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 54 PARTICLE SIZE ANALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 55 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 57 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 59 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 60 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 61 NORTH AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUBINDUSTRY, 2024–2031 (USD MILLION)
TABLE 62 US: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 63 US: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 64 CANADA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 65 CANADA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 68 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 69 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 70 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71 EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 72 EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 73 GERMANY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 74 GERMANY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75 UK: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 76 UK: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 77 FRANCE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 78 FRANCE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 79 ITALY: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 80 ITALY: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81 SPAIN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 82 SPAIN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 84 REST OF EUROPE: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 88 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 89 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 91 ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 92 CHINA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 93 CHINA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 JAPAN: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 95 JAPAN: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96 INDIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 97 INDIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 98 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 99 AUSTRALIA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 101 SOUTH KOREA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 103 REST OF ASIA PACIFIC: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 106 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2021–2028(USD MILLION)
TABLE 108 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 110 LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 111 BRAZIL: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 112 BRAZIL: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113 MEXICO: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 114 MEXICO: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 116 REST OF LATIN AMERICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY DISPERSION, 2024–2031 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR HEALTHCARE INDUSTRY, BY SUB-TYPE, 2024–2031 (USD MILLION)
TABLE 124 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 125 GCC COUNTRIES: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 127 REST OF MIDDLE EAST & AFRICA: PARTICLE SIZE ANALYSIS MARKET FOR IMAGING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 129 PARTICLE SIZE ANALYSIS MARKET: DEGREE OF COMPETITION
TABLE 130 PARTICLE SIZE ANALYSIS MARKET: REGION FOOTPRINT
TABLE 131 PARTICLE SIZE ANALYSIS MARKET: TECHNOLOGY FOOTPRINT
TABLE 132 PARTICLE SIZE ANALYSIS MARKET: DISPERSION FOOTPRINT
TABLE 133 PARTICLE SIZE ANALYSIS MARKET: TYPE FOOTPRINT
TABLE 134 PARTICLE-SIZE ANALYSIS MARKET: END USER FOOTPRINT
TABLE 135 PARTICLE SIZE ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 136 PARTICLE SIZE ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 137 PARTICLE SIZE ANALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022 TO MARCH 2026
TABLE 138 PARTICLE SIZE ANALYSIS MARKET: DEALS, JANUARY 2022 TO MARCH 2026
TABLE 139 PARTICLE SIZE ANALYSIS MARKET: EXPANSIONS, JANUARY 2022 TO MARCH 2026
TABLE 140 SPECTRIS: COMPANY OVERVIEW
TABLE 141 SPECTRIS: PRODUCTS OFFERED
TABLE 142 SPECTRIS: DEALS, JANUARY 2021–APRIL 2026
TABLE 143 HORIBA: COMPANY OVERVIEW
TABLE 144 HORIBA: PRODUCTS OFFERED
TABLE 145 HORIBA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 146 HORIBA: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 147 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 148 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 149 ANTON PAAR GMBH: COMPANY OVERVIEW
TABLE 150 ANTOR PAAR GMBH: PRODUCTS OFFERED
TABLE 151 ANTOR PAAR GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 152 ANTOR PAAR GMBH: DEALS, JANUARY 2021–APRIL 2026
TABLE 153 ANTOR PAAR GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 154 BETTERSIZE INSTRUMENTS LTD.: COMPANY OVERVIEW
TABLE 155 BETTERSIZE INSTRUMENTS LTD.: PRODUCTS OFFERED
TABLE 156 BETTERSIZE INSTRUMENTS LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 157 BETTERSIZE INSTRUMENTS LTD: DEALS, JANUARY 2021–APRIL 2026
TABLE 158 BETTERSIZE INSTRUMENTS LTD.: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 159 NOVA VENTURES GROUP: COMPANY OVERVIEW
TABLE 160 NOVA VENTURES GROUP: PRODUCTS OFFERED
TABLE 161 FRITSCH GMBH: COMPANY OVERVIEW
TABLE 162 FRITSCH GMBH: PRODUCTS OFFERED
TABLE 163 FRITSCH GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2026
TABLE 164 LS INSTRUMENTS: COMPANY OVERVIEW
TABLE 165 LS INSTRUMENTS: PRODUCTS OFFERED
TABLE 166 LS INSTRUMENTS: DEALS, JANUARY 2021–APRIL 2026
TABLE 167 LS INSTRUMENTS: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 168 METTLER TOLEDO: COMPANY OVERVIEW
TABLE 169 METTLER TOLEDO: PRODUCTS OFFERED
TABLE 170 VERDER SCIENTIFIC GMBH & CO. KG: COMPANY OVERVIEW
TABLE 171 VERDER SCIENTIFIC GMBH & CO. KG: PRODUCTS OFFERED
TABLE 172 VERDER SCIENTIFIC GMBH & CO. KG: DEALS, JANUARY 2021–APRIL 2026
TABLE 173 VERDER SCIENTIFIC GMBH & CO. KG: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 174 SYMPATEC GMBH: COMPANY OVERVIEW
TABLE 175 SYMPATEC GMBH: PRODUCTS OFFERED
TABLE 176 SYMPATEC GMBH: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 177 SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 178 SHIMADZU CORPORATION: PRODUCTS OFFERED
TABLE 179 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2021–APRIL 2026
TABLE 180 TSI: COMPANY OVERVIEW
TABLE 181 TSI: PRODUCTS OFFERED
TABLE 182 DANDONG HMKTEST INSTRUMENT CO., LTD.: COMPANY OVERVIEW
TABLE 183 DANDONG HMKTEST INSTRUMENT CO., LTD.: PRODUCTS OFFERED
TABLE 184 MICROMERITICS INSTRUMENT CORPORATION: COMPANY OVERVIEW
TABLE 185 MICROMERITICS INSTRUMENT CORPORATION: PRODUCTS OFFERED
TABLE 186 MICROMERITICS INSTRUMENT CORPORATION: DEALS, JANUARY 2021–APRIL 2026
TABLE 187 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH: COMPANY OVERVIEW
TABLE 188 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.: COMPANY OVERVIEW
TABLE 189 3P INSTRUMENTS: COMPANY OVERVIEW
TABLE 190 IZON SCIENCE LIMITED: COMPANY OVERVIEW
TABLE 191 CSC SCIENTIFIC COMPANY, INC.: COMPANY OVERVIEW
TABLE 192 INPROCESS-LSP: COMPANY OVERVIEW
TABLE 193 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC: COMPANY OVERVIEW
TABLE 194 APIX ANALYTICS: COMPANY OVERVIEW
TABLE 195 GENIZER LLC: COMPANY OVERVIEW
TABLE 196 TECHNOVALUE: COMPANY OVERVIEW
TABLE 197 PARTICLE SIZE ANALYSIS MARKET: RESEARCH ASSUMPTIONS
TABLE 198 RISK ASSESSMENT ANALYSIS
In this report, the global particle size analyzers market is classified into six segments based on the type of technology used in the analysis of particle size. It includes laser diffraction, dynamic light scattering (DLS), imaging, nanotechnology particle analysis (NTA), Coulter Principle, and others. The others segment comprises resonant mass measurement, laser obscuration, sedimentation, and sieve analysis. The laser diffraction segment accounted for the largest share of the global particle size analyzers market at an estimated $XX million in 2013, while the imaging technology market is expected to grow at the highest CAGR of XX% in the forecast period. Increasing demand of more precise and accurate size analyzing solutions and technological advancements in imaging technologies are the key factors stimulating the growth of the imaging technology-based particle size analyzers market.
On the basis of type of dispersion, the global particle size analyzers market has been segmented into wet, dry, and spray particle size analyzers. In 2013, the wet particle size analyzers segment accounted for a share of XX% of the particle size analyzers market, by type of dispersion, and is poised to grow at the highest CAGR of XX% from 2013 to 2018. Increase in the number of launches of different wet particle size analyzers and rising demand for nanoparticle analyzing instruments are the key factor propelling the growth of this segment.
On the basis of type of industry, the global particle size analyzers market is classified into five categories, namely, healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and others (inks, toners, paints, coatings, cosmetics, and environmental analysis). The healthcare industry is the fastest growing segment in this market, owing to the increasing application of nanotechnology in medical science and the rapid growth of pharmaceutical and biopharmaceutical products.
North America commanded largest share—XX%—of the global laser diffraction particle size analyzers market at an estimated $XX million in 2013 and it is expected to reach $XX million by 2018, at a CAGR of XX% from 2013 to 2018. However, the Asia-Pacific laser diffraction particle size analyzers market is estimated to grow at the highest CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. Rapidly growing traditional markets such as pharmaceuticals, mining and minerals, chemicals, and petroleum, in developing countries are propelling the growth of the laser diffraction particle size analyzers market in the Asia-Pacific region.
